Legis Daily

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

USA116th CongressHR-2038| House 
| Updated: 5/15/2019
Mark Meadows

Mark Meadows

Republican Representative

North Carolina

Cosponsors (2)
Debbie Lesko (Republican)Ted Budd (Republican)

Administrative State, Regulatory Reform, and Antitrust Subcommittee, Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019 This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 2, 2019
Introduced in House
Apr 2, 2019
Referred to the House Committee on the Judiciary.
May 15, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
  • April 2, 2019
    Introduced in House
  • April 2, 2019
    Referred to the House Committee on the Judiciary.
  • May 15, 2019
    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Health

Related Bills

  • S 116-4796: Fair Care Act of 2020
  • HR 116-8527: Fair Care Act of 2020
CancerChild healthChild safety and welfareCongressional oversightDrug, alcohol, tobacco useHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingLong-term, rehabilitative, and terminal carePrescription drugsRural conditions and developmentSales and excise taxesState and local finance

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

USA116th CongressHR-2038| House 
| Updated: 5/15/2019
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019 This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 2, 2019
Introduced in House
Apr 2, 2019
Referred to the House Committee on the Judiciary.
May 15, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
  • April 2, 2019
    Introduced in House
  • April 2, 2019
    Referred to the House Committee on the Judiciary.
  • May 15, 2019
    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Mark Meadows

Mark Meadows

Republican Representative

North Carolina

Cosponsors (2)
Debbie Lesko (Republican)Ted Budd (Republican)

Administrative State, Regulatory Reform, and Antitrust Subcommittee, Judiciary Committee

Health

Related Bills

  • S 116-4796: Fair Care Act of 2020
  • HR 116-8527: Fair Care Act of 2020
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerChild healthChild safety and welfareCongressional oversightDrug, alcohol, tobacco useHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingLong-term, rehabilitative, and terminal carePrescription drugsRural conditions and developmentSales and excise taxesState and local finance